Green Pharmaceuticals markets its own unique brand of natural anti-snoring OTC medicines currently distributed into 50% of national retail chains. It owns 50% market share over two remaining competitors marketing nasal dilators plastic devices. We have a plan to become the undisputed category leader with 80% distribution and 80%market share and over $50M of sales in the next 5 years. To finance this accelerated growth we need $0.7 M